Navigation Links
MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
Date:2/27/2008

gestion in recipients of all ages, fever more than 100 degrees F in children two to six years of age, and sore throat in adults.

FluMist may not protect all individuals receiving the vaccine. FluMist is for intranasal administration only.

Please see complete Prescribing Information for FluMist, call 1-877- FLUMIST (1-877-358-6478) or visit http://www.flumist.com for additional information.

Pricing and Insurance Coverage

FluMist is priced per-dose to be competitive with the flu shot. In addition, 94 percent of health insurance plans with immunization benefits provide coverage for FluMist, which is also available to eligible children at no cost through the federal Vaccines for Children (VFC) program.

About MedImmune

MedImmune strives to provide better medicines to patients, new medical options for physicians and rewarding careers to employees. Dedicated to advancing science and medicine to help people live better lives, the company is focused on cardiovascular/gastrointestinal disease, neuroscience, oncology, infection, respiratory disease and inflammation. With approximately 3,000 employees worldwide and headquarters in Maryland, MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN). For more information, visit MedImmune's website at http://www.medimmune.com.

(1) King JC, et al. N Engl J Med. 2006;355:2523-2532.

(2) Hurwitz ES, et al. JAMA. 2000;284:1677-1682.

(3) In past studies, FluMist has not provided protection against

different-lineage, mismatched B strains.

FLU08-030


'/>"/>
SOURCE MedImmune
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. MedImmune Expands Scientific and Engineering Leadership
2. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
3. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
4. MedImmune to present RSV surveillance and cost-effectiveness data at American Academy of Pediatrics
5. Medimmune announces phase 2 safety data for anti-RSV antibody and national RSV surveillance results
6. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
7. MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
8. Check Your Emergency Preparedness Kits When You Set Your Clocks, Says New American Public Health Association Campaign
9. TFAH Applauds Release of CDCs State-Specific Public Health Emergency Preparedness Report
10. K-State Trauma Researcher Says Being Prepared, Taking Action Are Vital in Preventing Tragedies Like the One at NIU
11. Many States Still Fall Short in Emergency Preparedness: Report

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ividualsintheRecommendedPriorityGroups ,, HARRI...rtmentofHealthannouncedtodaytheywillconductthreead...ntersinDelaware,Lancaster,andLehighcountiesonTuesd...administeredforfreetoindividualsintherecommendedta....Thedepartmentasksthatonlyindividualsinthefollowin...
(Date:11/23/2009)...nds appears to cause oxidative DNA damage and to i...study published online November 23 in the Journal...iomethylation was once believed to detoxify inorga...city and potentially its carcinogenicity. , To...ative DNA damage in mice, Michael P. Waalkes, Ph.D...
(Date:11/23/2009)...ren who don,t access health care from the same pla...y more likely to have unmet health care needs comp...shed in the journal Pediatrics . , Studies lik...delivery of quality health care for children, the ...bates about health insurance reform, much of the f...
(Date:11/23/2009)...rst-of-its-kind consensus statement on diabetes su...Surgery . The report illustrates the findings of t...betes Surgery Summit (DSS) -- where an internation...perts agreed on a set of evidence-based guidelines...nd study of gastrointestinal surgery to treat type...
(Date:11/23/2009)...hemo deal with insomnia, study shows , ,...sleep disorders affect more than three-quarters of...early three times higher than that of the general ... more common in younger patients and in those with...ster Medical Center researchers, who assessed slee...
Breaking Medicine News(10 mins):Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5
...ate program that focuses on the most lethal aspect...f Texas M. D. Anderson Cancer Center with support ...y of Texas System. , The Graduate Program in Canc... The program will be offered through The Universit...
...w COBRA legislation passed and unemployment number...answers about COBRA benefits and the new stimulus ...s consumers a resource into the changes of COBRA,s... on the recent legislation. , ...
...d of Hearing Now Provides Caller ID , , NEW YORK...an evolutionary Caller ID feature through PhoneCap...s. Until now, Hard of Hearing (late/accidental los.... PhoneCaption is now the first and only consumer...
... will be deployed in new Monitors that will detect..., LOS ANGELES, March 26 Pulse-oximeters are the m...xygen and pulse rate and have been in use since th...echnology was invented over 20 years ago and relie...
...Institute of Public Health shows a positive link b...ne) zopiclone in the blood and the chance of being...he study also included drivers who only showed alc...s or sleep-inducing medicines as we have for alcoh...
...acy benefit manager Prime Therapeutics (Prime) ann...rick Gleason, PharmD, FCCP, BCPS, Cathy Starner, P...Journal of Managed Care Pharmacy (JMCP) Award of E...risk for an adverse cardiovascular event. , , Pri...
Other Medicine News:Health News:M. D. Anderson launches graduate program in cancer metastasis 2Health News:COBRA-Answers.com Addresses Consumer Concerns Over COBRA Legislation 2Health News:COBRA-Answers.com Addresses Consumer Concerns Over COBRA Legislation 3Health News:COBRA-Answers.com Addresses Consumer Concerns Over COBRA Legislation 4Health News:American Network, Inc. Offers Revolutionary Service to Hard of Hearing 2Health News:Next Generation Optical Technology Has Potential to Greatly Improve Patient Safety 2Health News:Large users of zopiclone assessed as impaired 2Health News:Prime Pharmacists Recognized by the Journal of Managed Care Pharmacy 2
(Date:11/23/2009)...LASVEGAS,Nov.23/PRNewswire-FirstCall/--CordBloodAm...bloodstemcellpreservationcompany( http://www.cordb...tentialofstemcells,abiologicalinsurancepolicy,tofa...hatanupdatedprogressinterviewwithCEOandco-founderM...rviewisat: http://blip.tv/file/2875811 . ,, Int...
(Date:11/23/2009)...PRINCETON,N.J.,Nov.23/PRNewswire-FirstCall/--Pharm...llmentofCohort2,ledbyitspartnerRoche(SWX:ROG.VX;RO...type1and4patientsintheongoingphase2btrialofRG7128,...forthetreatmentofchronichepatitisCvirus(HCV)infect...independentDataMonitoringCommittee(DMC)ofallavaila...
(Date:11/23/2009)...NOVATO,Calif.,Nov.23/PRNewswire-FirstCall/--Raptor...: RPTP ),todayannouncedresultsfromaPhase2bclinical...rtrate("DRCysteamine")inpatientswithnephropathiccy...ersityofCalifornia,SanDiego("UCSD")GeneralClinical...cokineticsandpharmacodynamicsofasingledoseofDRCyst...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 1AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 2AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 3AFB Senior Site Offers New Information to Help Senior Citizens Manage Diabetes and Vision Loss 61313 4Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 1Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 2Misonix Announces New Distribution Agreement For The United Arab Emirates 28UAE 29 6255 3Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 1Custom Spine Launches Pathway AVID and Regent ACP at NASS 6251 2
...in sodium injection) were also less likely ...DGEWATER, N.J., Dec 10 Sanofi-aventis,announced t...l hospital,direct medical costs associated with VT...hey were treated with the use of low-molecular wei...) with 97.3% of LMWH patients,receiving Lovenox. P...
...ced leukemia and myelodysplastic, syndrome patien...eting., PRINCETON, N.J., Dec. 10 Celator Pharmac...hase I study of CPX-351, a liposomal,formulation t... and,daunorubicin for the treatment of advanced le...escalation in the study is ongoing, thus far three...
Other Medicine Technology:Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 2Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 3Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 4Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH) 5Celator(R) Pharmaceuticals Reports CPX-351 Shows Anti-Cancer Activity in Leukemia Patients 2